Sowell Financial Services LLC Alaunos Therapeutics, Inc. Transaction History

Sowell Financial Services LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 07, 2021	SELL	$2.82 - $5.6 $355 - $705	-126 Closed	0 $0
Q4 2020 Jan 13, 2021	SELL	$2.09 - $3.09 $555 - $821	-266 Reduced 67.86%	126 $0
Q4 2019 Feb 07, 2020	SELL	$3.95 - $5.35 $1,058 - $1,433	-268 Reduced 40.61%	392 $1,000
Q3 2019 Nov 14, 2019	BUY	$4.13 - $6.94 $2,725 - $4,580	660 New	660 $3,000

92.6K

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $443M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

Get notified when there are updates to the investment portfolio of Sowell Financial Services LLC, based on Form 13F filings with the SEC.

Stay updated on Sowell Financial Services LLC with notifications on news.